aimosti

Skeptic's Lab

COMT and the 'warrior vs worrier' gene

One letter of DNA, the story goes, decides whether you are calm under fire or wired and anxious. The enzyme is real. The personality test is not.

The claim. Your COMT genotype (rs4680, Val158Met) sorts you into a calm, resilient 'warrior' or a sharp-but-anxious 'worrier', and you should pick supplements or nootropics to match your type.

Verdict. Real gene, real enzyme, real but small effect. It is not a personality test, and there is no good evidence for choosing supplements by COMT genotype.

COMT is a real enzyme that helps clear dopamine from the prefrontal cortex, and the common Val158Met variant does change its activity: the Met version is slower, the Val version faster. The measured differences in things like working memory and stress response are genuine on average but small, inconsistent between studies, and easily outweighed by sleep, training and context. A single common variant does not define temperament.

Where the 'warrior / worrier' story comes from

COMT (catechol-O-methyltransferase) breaks down dopamine and related signalling molecules. In the prefrontal cortex it is one of the main ways the brain clears dopamine. The Val158Met substitution, tagged by rs4680, swaps one amino acid and makes the enzyme less stable, so the Met form works more slowly and the Val form more quickly.

Early lab studies reported that Met carriers, with dopamine lingering a little longer, edged out Val carriers on some working-memory tasks, while Val carriers looked steadier under acute stress or pain. Someone compressed 'more dopamine, better memory, more reactive' against 'less dopamine, steadier under fire' into the catchy warrior-versus-worrier label, and a personality test was born.

What the evidence actually shows

The kernel is real: the effect of Val158Met on enzyme activity is well established. The behavioural story is where it falls apart. rs4680 explains only a sliver of the variation in any complex cognitive or personality trait, large studies have struggled to replicate the early cognition and anxiety links, and the effect, where it appears at all, is often described as U-shaped and task-dependent. The best amount of prefrontal dopamine depends on the situation, so neither allele is globally 'better'.

Temperament is shaped by thousands of variants plus a lifetime of environment. Pinning it on one common SNP is the textbook candidate-gene overreach that the field has spent two decades walking back.

The supplement and nootropic angle

Forums often pair a COMT genotype with a supplement plan: methyl donors, tyrosine, particular nootropics, or avoiding them. There is no robust trial evidence that choosing supplements by COMT genotype improves anything. The biochemistry is used to motivate the plan, but motivation is not evidence. The trials that would justify a rule like 'if Met/Met, take X' have not been done at the quality needed to act on them.

What Aimosti would (and wouldn't) show you

We report rs4680 in the exploratory Frontier section: your genotype, the real biochemical effect on enzyme activity, and an evidence label that states plainly that the behavioural 'warrior/worrier' story is mixed. It is framed as curiosity and walled off from the clinical report.

What we won't claim

We won't tell you that one common variant is your personality, predicts your stress response, or decides which supplement or nootropic to take. We won't dress a small, inconsistent average effect up as a framework for self-knowledge.

Bottom line. Real gene, real enzyme, real but small effect. It is not a personality test, and there is no good evidence for choosing supplements by COMT genotype.

Related: Frontier (exploratory research). Restated from: MedlinePlus Genetics: COMT gene · dbSNP: rs4680 · NHGRI-EBI GWAS Catalog: rs4680.

This is the kind of answer we give. See what your file says.